The Dr. My Le Trinh Case: A Regulatory System Under Serious Question
For more than four years, Dr. My Le Trinh has been fighting a battle that has grown far beyond one doctor’s professional future. At its centre lies a troubling question: how much power should health regulators hold, and what happens when that power is exercised without transparency or accountability?
Dr. Trinh’s case has become one of the most controversial disciplinary proceedings in Australia’s recent medical history. What began as a regulatory complaint has evolved into a prolonged conflict that now raises uncomfortable questions about the conduct of the Health Care Complaints Commission (HCCC) and the broader regulatory system overseeing Australian doctors.
The issues surrounding the case are not merely technical or bureaucratic. They go directly to the integrity of the processes used to investigate and discipline medical professionals. If those processes fail the basic standards of fairness, then public confidence in the system itself begins to erode.
The origins of the case trace back to 2021, when two complaints triggered emergency action against Dr. Trinh.
One complaint came from a toxicology intern at Westmead Hospital. Another was submitted under the name “John Smith.”
Those complaints led to an urgent Section 150 hearing, after which Dr. Trinh was suspended from practice. The suspension was imposed despite the absence of any formal patient complaint alleging harm.
For many observers, that fact alone raises a fundamental question: how does a doctor lose the ability to practise medicine indefinitely without a patient alleging injury or malpractice?
The situation became even more troubling as the investigation expanded.
According to Dr. Trinh, the two initial complaints were followed by a third complaint—one she alleges was effectively created by the Medical Council itself after her suspension. This complaint allowed regulators to dramatically broaden the scope of their investigation.
Once the investigation expanded, the demands placed on Dr. Trinh escalated rapidly.
Regulators sought extensive documentation from her practice, including records relating to patients who had not complained. They demanded her professional records, insurance information, curriculum vitae, and even vaccination status. Non-compliance, she says, carried the threat of severe penalties.
At the same time, patient records were seized from her clinic—records that reportedly stretched back more than a decade. From this material, six allegations were ultimately constructed, focusing largely on her prescribing of ivermectin during the COVID period.
To Dr. Trinh and her supporters, this process represents something deeply troubling: a regulatory investigation that appeared to grow in scope after the initial action had already been taken.
That concern is magnified by the role of the regulators themselves. Dr. Trinh argues that members of the Medical Council who suspended her later became complainants in the case—blurring the line between investigator and accuser.
If that allegation is correct, critics say it raises serious questions about whether the system preserved the impartiality expected of regulatory authorities.
The case has also been complicated by procedural issues during the tribunal process.
One of the HCCC’s expert witnesses died before cross-examination could take place. Concerns were raised about legal representation, transcript accuracy, and the fairness of the proceedings. Applications were made seeking adjournments or stays, but the NSW Civil and Administrative Tribunal (NCAT) rejected them, concluding that Dr. Trinh was capable of continuing to represent herself.
The personal consequences of this prolonged process have been severe.
Dr. Trinh has remained suspended from practice for years while attempting to defend herself in complex legal proceedings. She has described financial hardship, psychological strain, and the enormous burden of confronting the regulatory system largely on her own.
Despite those challenges, she has continued to speak publicly about the case.
Her disclosures—through public statements, social media posts, podcasts, and parliamentary submissions—have brought the case to wider attention. A petition supporting her position has gathered thousands of signatures. Her story has circulated widely among doctors and commentators who question whether the regulatory framework provides sufficient safeguards against overreach.
Supporters view her campaign as a necessary exposure of systemic flaws. They argue that if regulators can expand investigations without clear boundaries, rely on anonymous complaints, and demand extensive records unrelated to the original allegation, then any doctor could find themselves in a similar situation.
Critics of Dr. Trinh take a very different view. They argue that regulators must act decisively when concerns arise about patient safety or controversial treatments. They also point to legal rulings—including a 2024 decision by the NSW Court of Appeal dismissing one of her appeals—as evidence that the judicial system has already considered and rejected some of her arguments.
Yet even critics acknowledge that the case has raised uncomfortable questions about how complaints are initiated, investigated, and prosecuted within Australia’s medical regulatory system.
At stake is more than one doctor’s reputation.
If regulators possess the authority to suspend practitioners, seize records, and build cases over many years, then the public must be confident those powers are exercised transparently, fairly, and with clear limits.
Without that confidence, the entire framework of professional regulation begins to look less like a safeguard and more like an unchecked bureaucracy.
Dr. Trinh’s case has therefore become a lightning rod in a larger debate: where is the line between legitimate oversight and regulatory overreach?
That debate is unlikely to disappear.
Whatever the final outcome of her proceedings, the questions raised by this case will continue to resonate—because they strike at the heart of how power is exercised in Australia’s medical system.
And when that power is questioned, the demand for answers does not simply fade away.
Leave a Reply